Filing Details
- Accession Number:
- 0001171843-17-004905
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-09 18:01:19
- Reporting Period:
- 2017-08-04
- Filing Date:
- 2017-08-09
- Accepted Time:
- 2017-08-09 18:01:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 3116 | Akorn Inc | AKRX | Pharmaceutical Preparations (2834) | 720717400 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1467848 | Brian Tambi | 1925 West Field Court Suite 300 Lake Forest IL 60045 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-08-04 | 5,165 | $33.37 | 66,175 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the weighted average sale price of the shares sold. The shares were sold at prices ranging from $33.35 to $33.44. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at separate prices within the foregoing range.
- Following the reported transaction, the amount of shares beneficially owned includes 14,434 unvested RSUs and 51,741 shares owned outright.
Billionaire Hedge Funds
